BeiGene - Multiplikator nilai perusahaan marang pendapatan ONC

Simbol resmi perusahaan BeiGene (ONC)

BeiGene Ltd is a biotechnology player facing severe pricing pressure from China and geopolitical tensions. The enterprise value-to-revenue ratio, illustrated by this chart from the GURU.Markets system, highlights the impact of these risks, where the value 5780.38 serves as the baseline indicator. BeiGene Ltd is reducing its dependence on China through the global export of its drugs. Innovations are based on targeted therapy that minimizes treatment toxicity.

ONC: Multiplikator EV/Sales BeiGene 23.11.2025 - 20.11.2026

ONC (BeiGene Corp): rincian analitis lan laporan miturut indikator

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental:BeiGene Ltd (ONC)
Sampel barang BeiGene Ltd.

Investors must identify an objective entry point based on the intrinsic value of BeiGene Ltd assets. The presence of high-tech manufacturing plants in the US and China ensures stable drug production, establishing revenue as a reliable basis for valuation. Analyzing the enterprise value-to-revenue chart allows for a business assessment independent of debt load, defining fair price corridors to minimize the risk of overpayment.

Analisis pesaing BeiGene Ltd

HALO: Rasio nilai perusahaan marang pendapatan|Revolution Medicines Corp (RVMD) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Ascentage Pharma Group International (AAPG)|Rasio nilai perusahaan marang pendapatan CG Oncology, Inc.|Multiplikator nilai perusahaan marang pendapatan UroGen Pharma Corp URGN|Multiplikator EV/Sales BCAX|Personalis, Inc. - Rasio nilai perusahaan marang pendapatan|Erasca - Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan DCTH|YMAB: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Aura Corp|CADL: Multiplikator EV/Sales|ARAY - Rasio total nilai perusahaan marang pendapatan|SLS (SELLAS Life Sciences Group, Inc.) - Multiplikator EV/Sales|ACTU: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan citiusonc.com (CTOR)|Rasio total nilai perusahaan marang pendapatan TuHURA Biosciences|Rasio nilai perusahaan marang pendapatan Protara Therapeutics TARA|Fate Therapeutics (FATE) - Multiplikator nilai perusahaan marang pendapatan|WHWK - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan TScan Therapeutics Inc|championsoncology.com (CSBR) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan XBIT|Nilai perusahaan marang pendapatan CVM|Rasio nilai perusahaan marang pendapatan OSTX (OS Therapies Incorporated)|Multiplikator EV/Sales RADX|ARTV: Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales ANL (Adlai Nortye Ltd)|VERU - Nilai perusahaan marang pendapatan|tempesttx.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan XLO (xiliotx.com)|RENB: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Mural Oncology plc|Rasio nilai perusahaan marang pendapatan Kairos Pharma Inc|OKUR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales GDTC|CRIS (Curis) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan apollomicsinc.com APLM|THAR: Rasio nilai perusahaan marang pendapatan|advanbiomed.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan GNPX (Genprex, Inc)|Calidi Biotherapeutics Inc. (CLDI) - Rasio nilai perusahaan marang pendapatan|Sunshine Biopharma Inc. (SBFM) - Multiplikator EV/Sales|XBIO (Xenetic Bio) - Multiplikator EV/Sales|Salarius Pharmaceuticals Inc (SLRX) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales PPBT|Multiplikator EV/Sales American Oncology Network Inc (AONC)|Multiplikator EV/Sales BGNE (BeiGene Ltd.)|Koefisien nilai perusahaan marang pendapatan CKPT (Checkpoint Therapeutics)|ELEV - Rasio nilai perusahaan marang pendapatan|ICAD (iCAD Inc.) - Rasio nilai perusahaan marang pendapatan|Ikena (IKNA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Notable Labs, Ltd.|Rasio nilai perusahaan marang pendapatan viracta.com|MOR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales NAYA|Ascentage Pharma - Rasio nilai perusahaan marang pendapatan